01 / THE DESIGN
1. Establish an executive mandate that connects decisions to delivery
The network begins with a governing agreement rather than a technology purchase. Name the sponsor, participating entities, delegated authority, employment and delivery funding, and escalation rights. An integration executive owns the cross-functional roadmap, accepted local commitments, dependency resolution, and decision quality. Clinical leadership approves care pathways; center leaders control staffing and scheduling; finance certifies economic commitments. Outcome accountability must follow the authority that can change the result.
Start with one willing center, one payer-product, and one clinically material workflow. Produce a current entity/program/site roster, partner service catalog, contract rulebook, source inventory, capacity certificate, and baseline. An existing paid service should be understood before a duplicate function is purchased. Weekly local reviews resolve barriers to patient work. A monthly operating council integrates workload, evidence, funding, and risk. Governing reviews release investment and resolve tradeoffs that exceed delegated authority. Each decision records alternatives, evidence, owner, resource effect, conditions, and next review. Calendar milestones trigger these decisions; they do not authorize production. Leadership and regional coordination must be funded from the beginning, with discovery and later expansion separately costed.
02 / THE DESIGN
2. Keep program economics distinct inside a shared operating foundation
Maintain different registers for legal entities, physical sites, program participation, coverage, attribution, and care responsibility. A member of a network is not automatically an implementation-ready site; an electronic-record panel is not necessarily a payer-assigned population. Identity uncertainty remains an owned exception rather than an automatic merge. Record effective dates and the date information was received so retroactive changes can be reconstructed without rewriting history.
Shared infrastructure may support Medicaid, Medicare accountable-care arrangements, Medicare Advantage, commercial contracts, health-center reporting, and uninsured care. Their populations, measures, earning conditions, and money flows remain separate. Each contract needs a compact operating annex: recipient, eligible population and period, obligations, measure version, fee conditions, data cadence, evidence route, acceptance detail, dispute rights, settlement lag, downside, termination, and data rights. Bind every worklist and financial assumption to the applicable version. A quality rating, a billed encounter, a care-management month, and a shared-savings settlement are different units. Clinical access extends beyond incentive-eligible panels through the center's mission and separately funded pathways.
03 / THE DESIGN
3. Close clinical obligations before declaring a pathway complete
Use distinct states for contact, accepted appointment, completed care, clinical follow-up, measure satisfaction, evidence submission, payer acceptance, and payment. First validate identity, current responsibility, and available outside evidence. Recover a valid existing report before scheduling duplicate care. When new care is needed, confirm communication preferences and receiving capacity. The initiating team retains responsibility until a qualified receiving team accepts the handoff. An appointment booked or referral transmitted is an intermediate event.
For diabetes follow-up, distinguish a documented laboratory value from clinician review, a feasible plan, medication safety, and reassessment. For colorectal screening, track ordered, issued, returned, resulted, and reviewed; an abnormal result opens a separate diagnostic obligation even if screening receives measure credit. For discharge transitions, reconcile medicines, pending tests, patient understanding, and actual follow-up. Behavioral, maternal, pediatric, kidney, and older-adult pathways each retain their own clinical owner and approved urgency route. A source correction can reopen an evaluation; a payer rejection can reopen evidence work without erasing completed care. Where payer feedback is aggregate, report acceptance at that grain and disclose that patient-level acceptance is unavailable.
04 / THE DESIGN
4. Make capacity a release condition, with regional support behind the center
A center capacity certificate should document protected productive staff minutes, appointment availability, interpreter access, navigation, diagnostic and referral slots, abnormal-result follow-up, backup coverage, and downtime procedures. Nominal staffing does not equal usable production time. Observe failed contacts, preparation, review, rework, exception handling, training, and displaced work. Usable episodes equal protected productive minutes divided by observed total minutes per episode. Downstream throughput is constrained by the smallest essential receiving capacity.
The local owner accepts work and monitors aging; the regional manager removes cross-center barriers without creating a second patient queue. Clinical-quality specialists approve boundaries and review exceptions. Navigators, care managers, community health workers, and pharmacists operate within agreed scopes, while data support absorbs mapping and interface problems. Backlog equals prior backlog plus released episodes minus completed and validly disposed episodes. Dispositioning an outreach item never erases an unresolved clinical obligation. Co-design, competency sign-off, and a weekly capacity review precede volume expansion. When necessary, throttle new elective outreach while protecting abnormal-result response and continuity. Released time is capacity; cash savings require an actual reduction in paid expense.
05 / THE DESIGN
5. Treat social needs and patient trust as delivery infrastructure
Social-needs work starts with assistance the patient wants and a receiving service that can actually deliver. Preserve separate states for declined screening, no identified need, identified need, accepted help, unavailable resource, delivered service, and reassessed barrier. Confirm eligibility, funding, language access, cost, capacity, and permission before promising support. Infrastructure funding can improve referral coordination without purchasing food, housing, transport, or other services. Each funding stream therefore needs its own recipient, allowable activity, allocation, earning condition, and cash date.
Maintain telephone and in-person alternatives alongside digital channels. Coordinate attempts across authorized workflows, respect contact preferences, and explain why the responsible care team is contacting the person. Patient and community representatives should review repeated outreach, referral burden, accessibility, and complaints. Measure completion and workload by appropriate geography, language, access needs, and other approved categories, with sample size and missingness visible. Improving the average must not conceal widening access gaps. Social-resource receipt, patient-reported benefit, clinical improvement, measure credit, and reimbursement remain separate outcomes. Uninsured patients and people whose coverage changes still need an accountable continuity pathway.
06 / THE DESIGN
6. Place agent assistance inside a controlled data and action architecture
Preserve raw source records and corrections, then build trusted identity, coverage, attribution, and clinical facts. A versioned rule service evaluates facts; one authoritative workflow service assigns work. Evidence and finance events remain linked but retain different states and permissions. Authorized interfaces need documented rights, enabled capabilities, control totals, freshness checks, and tests for duplicates, reversals, late data, and ambiguous responses. Public standards or portal access do not establish production read or write rights.
Four bounded assistants support evidence organization, workflow drafting, approved-contract interpretation, and exception monitoring. They may summarize cited records, identify missing evidence, draft tasks, and explain reconciliation issues. Clinicians retain diagnosis, urgency, treatment, orders, and patient instructions; finance and contracting certify economic interpretation. Consequential dispatch requires exact approval bound to person, center, action, destination, normalized payload hash, policy version, and expiry. Recheck current authority, consent, source freshness, and capacity at execution. Enforce business-action uniqueness independently of retry keys; reconcile an unknown external result before retrying. Test altered payloads, cross-center mismatches, revoked permissions, unsupported citations, malicious record instructions, outages, and corrected results. Changes to models, prompts, rules, connectors, or measures require scoped revalidation and a tested fallback.
07 / THE DESIGN
7. Underwrite incremental care, entity liquidity, and the labor actually required
The economic funnel begins with deduplicated, clinically appropriate opportunities after existing evidence, bookings, and exclusions. Apply reach, scheduling, completion, qualified service, earning, and collection assumptions separately; cap delivery at staffed capacity. Distinguish new care from recovered historical evidence, displaced activity, and care that would occur without the intervention. A simplified illustration can explore these relationships, but production records must keep quality acceptance and claim adjudication separate.
The author's illustrative 25-cohort model applies each new center's own six-month maturation curve. That correction changes first-year modeled operating loss from approximately $231,000 to $379,000 and attributable cash use from approximately $606,000 to $729,000. These are scenario calculations, not observed performance. A separate hypothetical navigation-labor stress changes a positive mature monthly result into a loss. Cheap inference does not compensate for unfunded clinical coordination.
Prepare recognition, settlement, and cash views by legal entity, plus a rolling 13-week forecast. Center receipts cannot fund central obligations without an authorized transfer agreement. Eliminate internal fees from combined external revenue and count each economic event once. Keep unexecuted incentives, unawarded grants, and assumed shared savings out of committed funding. Accountable-care downside needs a separate benchmark, claims-maturity, repayment, reserve, and participant-allocation analysis; additional reimbursed care may increase provider income while increasing program expenditure.
08 / THE DESIGN
8. Expand through evidence gates and explain what actually changed
Release the design through six reversible gates: funded mandate, trusted data and workflow, read-only validation, assisted operation, bounded external action, and selective scale. Each brief states the affected population, evidence reviewed, residual risk, spend, owner, expiry, and rollback. Unsupported rights, uncertain identity, unsafe follow-up, duplicate effects, exhausted capacity, or unfunded commitments hold the affected path. Ordinary care continues through its approved process.
The first 90 days produce decision-ready briefs and a selective expansion, redesign, continued-validation, or stop decision; they are not a guaranteed launch schedule. Explain variance across newly delivered care, recovered evidence, mapping fixes, denominator changes, payer response, price, costs, and collection timing. Use stable snapshots, mature data, comparable periods, and credible comparison groups where feasible. Early feasibility is different from a controlled estimate and sustained finance-reconciled performance. A multiyear horizon guides annual portfolio decisions rather than inventing a revenue curve. Reliable execution earns options to add pathways, sites, geography, risk, and automation; each option still requires its own funded evidence case.
THE DELIVERY SEQUENCE
Release the next commitment when the evidence is ready.
G0 — Fund the mandate
Sponsor and participant authority, executive charter, bounded workflow, named funding entity, cash ceiling, and approved discovery access.
Decision: Approve discovery and accountable leadership without presuming production or later expansion.
G1 — Certify the operating baseline
Effective-dated roster, contract annex, source rights, measure registry, baseline, clinical owner, and center capacity certificate.
Decision: Proceed only when the chosen patient pathway is both permitted and deliverable.
G2 — Validate without external effects
Reference-case concordance, source lineage, missingness, shadow workflow, corrected-result behavior, and no unauthorized action.
Decision: Repair the limiting data or workflow step before patient-facing operation.
G3 — Release human-reviewed assistance
Trained staff, authoritative queue, permission and review rules, receiving-team acknowledgment, follow-up ownership, and fallback.
Decision: Allow bounded assisted work within existing clinical and operational authority.
G4 — Permit a defined external action
Exact approval binding, live context checks, allowed destination, business uniqueness, receipts, reconciliation, and rollback tests.
Decision: Release only the specifically validated action path; hold uncertain effects for review.
G5 — Expand selectively
Reliable care and evidence return, acceptable burden and access, entity cash plan, resilience, local agreement, and new-cohort maturation assumptions.
Decision: Add a center or pathway only when its own readiness and funding are certified.
WHO OWNS THE DECISION
Authority travels with accountability.
Governing sponsor and integration executive
- Decision
- Approve strategic priorities, delegated authority, roadmap, investment releases, partner alignment, and material scope changes.
- Escalation
- Unresolved authority, cross-functional dependency, or unapproved commitment returns to the sponsor with options and the affected delivery path identified.
Clinical-quality leader and local clinical owners
- Decision
- Approve pathway appropriateness, clinical protocols, abnormal-result response, reference cases, and interpretation of clinical outcomes.
- Escalation
- Urgent patient concerns follow the established live clinical route; unsafe follow-up holds new affected outreach and activates backup ownership.
Center leader and regional operations owner
- Decision
- Certify staffing, scheduling, receiving capacity, training, queue ownership, workload, and local participation.
- Escalation
- Capacity exhaustion, aging clinical obligations, or competing priorities trigger volume reduction and a funded capacity or scope decision.
Data, technology, privacy, and security owners
- Decision
- Authorize source admission, interface scope, identity resolution, access boundaries, action dispatch controls, change release, and restoration.
- Escalation
- Untrusted data or unauthorized effects quarantine the affected records or disable the action path; reconciliation and explicit revalidation precede restart.
Contract owner and quality evidence owner
- Decision
- Certify contract version, measure logic, submission route, available acceptance grain, correction deadlines, and disputes.
- Escalation
- Ambiguous earning terms or unavailable payer response remain disclosed exceptions; no unsupported acceptance or value is manufactured.
Finance/controller and accountable-care governance
- Decision
- Approve cost allocation, recognition policy, cash forecasts, entity transfers, downside exposure, repayment arrangements, and distributions.
- Escalation
- Unfunded commitments or deteriorating liquidity hold discretionary expansion; material downside requires a separate actuarial and governing review.
Patient-access, community, and grants owners
- Decision
- Validate assistance preferences, accessible routes, active resource capacity, funding eligibility, restricted-cost allocation, and sustainability.
- Escalation
- Unavailable resources, repeated-contact burden, or restricted-fund mismatch create an owned exception and an alternative-care or revised-funding decision.
THE PERFORMANCE CONTRACT
A measure should change a decision.
Appropriate care completion
- Definition
- Completed clinically appropriate pathway events divided by released eligible care episodes, by workflow and period; unresolved follow-up is reported separately.
- Decision use
- Identify whether released work produces care, then repair delivery or reduce release volume.
Accepted evidence yield
- Definition
- Accepted unique packages divided by accepted plus rejected packages with final decisions, where observable; separately show all submitted, pending, disputed, and aged items.
- Decision use
- Improve evidence quality without removing difficult cases; use the payer-supported reporting grain.
Net cash and funded exposure
- Definition
- External receipts minus incremental cash outlays by legal entity, with cumulative funding need, commitments, and a separate recognition-based result.
- Decision use
- Authorize spending, protect liquidity, and prevent assumed center-to-central funding.
Reach and selection
- Definition
- Verified contacts divided by all eligible outreach episodes and separately by released episodes, stratified by approved access categories.
- Decision use
- Distinguish outreach effectiveness from selective release and expose unequal access.
Receiving capacity and backlog
- Definition
- Protected productive minutes, available essential slots, released/completed/disposed episodes, queue age, and displaced work.
- Decision use
- Throttle volume, fund the bottleneck, or revise the workflow before backlog becomes unsafe.
Abnormal-result accountability
- Definition
- Open actionable results with named owner, backup, due time, communication status, and documented disposition; report overdue count and oldest age.
- Decision use
- Protect clinical response independently of screening credit or financial acceptance.
Workforce and patient burden
- Definition
- Total observed minutes per completed episode including failed attempts, preparation, rework, and exceptions; overtime, repeat contacts, and patient feedback.
- Decision use
- Validate staffing economics and redesign burdensome steps instead of assuming automation savings.
Evidence and identity integrity
- Definition
- Source completeness, unresolved identity holds, corrected-source restatements, mapping errors, and reference-case concordance with period and version.
- Decision use
- Quarantine affected records, repair transformations, and assess whether apparent quality gain reflects better capture.
Claims-to-cash performance
- Definition
- Initial processing acceptance, initial/final adjudicated denials at claim-line and dollar grain, mature cohort collections, and service-to-claim and claim-to-cash lag.
- Decision use
- Route the correct remedy and forecast collectible cash without equating every denial with recoverable revenue.
Social-assistance delivery
- Definition
- Wanted and accepted assistance followed through receiving acknowledgment, actual service receipt, patient-confirmed outcome, and unresolved barrier status.
- Decision use
- Fund missing service capacity and distinguish referral activity from received help.
Authority and technical reliability
- Definition
- Unauthorized or duplicate consequential effects, stale sources, failed deliveries, unknown writes, restoration performance, and documented overrides.
- Decision use
- Disable the affected action path and require reconciliation and scoped revalidation.
Incremental effect and leadership execution
- Definition
- New care separated from recovered evidence and denominator changes, alongside accepted center plans, funded commitments, and unresolved decisions by age.
- Decision use
- Determine whether expansion has comparative operating value and whether governance resolves the constraints it controls.
THE CAPITAL AND CASH TEST
Earn the right to expand.
Track a unique opportunity through appropriate care, qualified economic event, recognition, settlement, and cash without collapsing these states. Estimate incremental contribution against a credible alternative, then subtract the full clinical, navigation, local, regional, technology, assurance, and continuing support cost. Apply maturation to every activation cohort. Separate opportunity cost from paid expense, and account for cash and downside by entity before evaluating combined economics.
Assumptions and model boundaries
- All following numbers belong to the author's hypothetical source illustration, not a named network, contract rate, observed result, rollout commitment, or forecast.
- The illustration models 25 cohorts, each progressing through 30%, 60%, 75%, 85%, 90%, and 100% maturity over its own first six operating months.
- At maturity, 350 deduplicated opportunities per center-month pass through assumed reach of 65%, scheduling of 50%, and completion of 85%, with a 150-completion capacity cap.
- The simplified economic funnel uses 95% valid evidence, 90% billability, 95% acceptance, 98% earning, a synthetic $150 unit yield, and a 65% retained incremental-effect factor. The resulting approximately $77.61 modeled revenue per completion is not a reimbursement quotation. Real quality and claims acceptance require separate event records.
- Illustrative delivery cost is $35 per completion; central recurring cost is about $61,167 per month; startup, onboarding, local support, and metered technology costs are additional. The complete cost boundary must be rebuilt from actual activity and contracts.
- Correcting cohort maturity produces approximately $949,251 modeled first-year attributable revenue, $1,328,298 cost, $379,046 operating loss, $728,731 attributable cash use, and $737,770 combined-net peak funding need. These are overlapping economic views, not amounts to add together.
- Without central receipts or an authorized contribution agreement, modeled central outlay is approximately $821,214; the positive netting of center receipts does not establish central access to that cash.
- A separate labor stress assumes six minutes per candidate, ten per reachable contact, five per booking, and five per completion: about 90.45 hours per mature center-month. At an illustrative $35 per hour, wholly incremental labor changes the source mature monthly result from about $35,143 surplus to $44,003 loss. Add labor only after checking whether it is already funded elsewhere.
- Collection lag changes cash timing rather than operating earnings. Unexecuted fees or incentives, unawarded grants, assumed shared savings, and unsupported cost avoidance remain zero in the committed funding case.
- A bounded discovery example allocates a $25,000 cash ceiling and separately identifies $9,000 of existing-capacity allocation; executive employment, continuing operations, and expansion require separate funding. Additional navigation, financing, taxes, opening working capital, and accountable-care downside must be included when material.
The expansion gate
Expand only after local care and evidence loops function, the required volume fits observed protected and downstream capacity, unit contribution remains acceptable under adverse assumptions, every entity has funded commitments and an authorized cash plan, and clinical, center, data/privacy, and finance owners approve. A positive mature month alone does not repay startup funding or justify new downside.
Design provenance
This blueprint adapts original strategy work authored by Azis R. Dabas. Organization, recipient and contact identifiers have been removed. Proposed workflows and illustrative economics are presented as design work; implementation and observed performance require their own evidence.